Milton Werner
Founder at INHIBIKASE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Milton H.
Werner is the founder of Inhibikase Therapeutics, Inc. which was founded in 2008.
He holds the title of President, Chief Executive Officer & Director at Inhibikase Therapeutics, Inc. starting in 2012.
Dr. Werner is currently a Member at Winship Cancer Institute.
In the past, he worked as Vice President-Research at Celtaxsys, Inc. in 2007 and as Head-Laboratory of Molecular Biophysics at The Rockefeller University from 1996 to 2007.
Dr. Werner completed his undergraduate degree at the University of Southern California in 1985 and obtained his doctorate degree from the University of California, Berkeley in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 889,230 ( 14.37% ) | 2 M $ | 2024-03-30 |
Milton Werner active positions
| Companies | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Founder | 2008-08-31 |
| Winship Cancer Institute | Corporate Officer/Principal | - |
Former positions of Milton Werner
| Companies | Position | End |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 2007-07-31 |
| The Rockefeller University | Corporate Officer/Principal | 2007-05-31 |
Training of Milton Werner
| University of Southern California | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Winship Cancer Institute |
- Stock Market
- Insiders
- Milton Werner